Coronary flow reserve in patients with heart failure with preserved ejection fraction

Aim. To study the parameters of myocardial blood flow (MBF) and coronary flow reserve (CFR) in patients with heart failure (HF) with preserved ejection fraction and evaluate their relationship with the severity of HF.

Material and methods. The study included 47 patients (men, 68,7%) aged 65,0 (58,0; 72,0) years with left ventricular ejection fraction of 62 (56; 67)% and coronary artery stenosis <50%. Serum levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) were assessed by enzyme immunoassay. MBF and CFR values were assessed using cardiac single photon emission computed tomography.

Results. Depending on NT-proBNP levels, the patients were divided into 2 groups (p<0,001): the 1st group included (n=15) patients with NT-proBNP <125 pg/ml (58,2 [41,6; 70,7] pg/ml), while in the 2nd group (n=32) — with NT-proBNP ≥125 pg/ml (511,4 [249,8; 1578,1] pg/ml). The group of patients with high NTproBNP levels was characterized by higher values (by 33,8%, p=0,0001) of resting MBF and reduced CFR (by 14,7%, p=0,001) compared with patients with normal NT-proBNP level: resting MBF — 0,65 (0,44; 0,79) vs 0,43 (0,30; 0,58) ml/min/g; CFR — 2,21 (1,52; 2,83) vs 2,59 (2,47; 3,05), respectively. At the same time, MBF at stress did not differ between the groups. The relationship of NTproBNP levels with global CFR (p=0,012; r=-0,339) and MBF at rest (p=0,012; r=0,322) was established. A stepwise decrease in global CFR was revealed depending on the NYHA class as follows (p<0,001): 2,79 (2,52; 2,93); 1,8 (1,55; 2,08); 1,31 (1,23; 1,49) — for class I, II, and III, respectively.

Conclusion. A decrease in CFR in patients with HF with preserved ejection fraction indicates impaired myocardial blood supply, which, in this group of patients, is associated with microcirculatory changes. At the same time, the severity of MBF alterations is closely related to HF severity.

1. Coma-Canellaa I, García-Vellosob M-J, Macíasa A, et al. Impaired Coronary Flow Reserve in Patients With Non-Ischemic Heart Failure. Rev Esp Cardiol. 2003;56(4):354-60. doi:10.1016/s0300-8932(03)76878-x.

2. Kop’eva KV, Teplyakov AT, Grakova EV, et al. Role of ST2 biomarker for the evaluation of myocardial remodeling in patients with ischemic heart failure with preserved ejection fraction. Kardiologiia. 2018;58(S10):33-43. (In Russ.) doi:10.18087/cardio.2498.

3. Rodríguez-Capitán J, Sánchez-Pérez A, Ballesteros-Pradas S, et al. Prognostic Implication of Non-Obstructive Coronary Lesions: A New Classification in Different Settings. J. Clin. Med. 2021;25;10(9):1863. doi:10.3390/jcm10091863.

4. Murthy VL, Naya M, Taqueti VR, et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014;129:2518-27. doi:10.1161/CIRCULATIONAHA.113.008507.

5. Driessen RS, Raijmakers PG, Stuijfzand WJ, et al. Myocardial perfusion imaging with PET. Int J Cardiovasc Imaging. 2017;33:1021-31. doi:10.1007/s10554-017-1084-4.

6. Mochula A, Zavadovsky K, Andreev S, et al. Dynamic single-photon emission computed tomography data analysis: capabilities for determining functional significance of coronary artery atherosclerosis. MATEC Web of Conferences. 2016;79:01080. doi:10.1051/matecconf/20167901080.

7. Zavadovsky KV, Mochula AV, Boshchenko AA, et al. Absolute myocardial blood flows derived by dynamic CZT scan vs invasive fractional flow reserve: Correlation and accuracy. J Nucl Cardiol. 2021;28(1):249-59. doi:10.1007/s12350-019-01678-z.

8. Agostini D, Roule V, Nganoa C, et al. First validation of myocardial flow reserve assessed by dynamic 99mTc-sestamibi CZT-SPECT camera: head to head comparison with 15O-water PET and fractional flow reserve in patients with suspected coronary artery disease. The WATERDAY study. Eur J Nucl Med Mol Imaging. 2018;45(7):1079-90. doi:10.1007/s00259-018-3958.

9. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016;37(27):2129-200. doi:10.1093/eurheartj/ehw128.

10. Mochula AV, Maltseva AN, Shipulin VV, et al. Evaluation of myocardial blood flow and coronary flow reserve — the physiological foundation and clinical significance of myocardial perfusion scintigraphy in the examination of patients with chronic coronary syndrome. Russian Journal of Cardiology. 2020;25(2):3649. (In Russ.) doi:10.15829/1560-40712020-2-3649.

11. Grakova EV, Kopieva KV, Teplyakov AT, et al. Association between the severity of coronary artery disease and ST expression in patients with heart failure. Russian Medical Inquiry. 2020;4(7):399-405. (In Russ.) doi:10.32364/2587-6821-2020-4-7-399-405.

12. Shah SJ, Lam CSP, Svedlund S, et al. Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF. Eur Heart J. 2018;39(37):3439-50. doi:10.1093/eurheartj/ehy531.

13. Manfrini O, Bugiardini R, Canty J, et al. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on ‘coronary microvascular dysfunction in cardiovascular disease’. Cardiovasc Res. 2020;116(4):741-55. doi:10.1093/cvr/cvaa003.

14. Kato S, Saito N, Kirigaya H, et al. Impairment of Coronary Flow Reserve Evaluated by Phase Contrast Cine-Magnetic Resonance Imaging in Patients With Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2016;5(2):e002649. doi:10.1161/JAHA.115.002649.

15. Camm JA, Luscher TF, Serruys PW. The ESC textbook of cardiovascular medicine. 2nd ed. Oxford: Oxford University Press, 2009:1398. ISBN 9780199566990.

16. Westermann D, Lindner D, Kasner M, et al. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail. 2011;4(1):44-52. doi:10.1161/CIRCHEARTFAILURE.109.931451.